Citius Pharmaceuticals, Inc. ( CTXR) - Stock Earnings
CTXR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -8.0 million USD | — USD |
| 2025Q4 | -8.2 million USD | 3.9 million USD |
| 2026Q1 | -28.1 million USD | 1.7 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CTXR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -32.5 million USD | — USD |
| 2024 | -39.1 million USD | — USD |
| 2025 | -37.4 million USD | — USD |
| 2026 Est. | — | — |
CTXR
Price: $0.55
52 week price:
Earnings Per Share: -2.46 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 674400
Ebitda: -9.5 millionMarket Capitalization: 6.5 million